Neuroleptic Malignant Syndrome Secondary to Quetiapine in Critical Care: A Case Report.
A A Pract
; 14(11): e01318, 2020 Sep.
Article
em En
| MEDLINE
| ID: mdl-32985851
ABSTRACT
Quetiapine, an atypical antipsychotic, is widely used to treat delirium in intensive care units (ICUs). Studies demonstrate its efficacy and favorable safety profile. We report a case of an elderly patient who developed clinical and biochemical evidence of neuroleptic malignant syndrome (NMS) 5 days after quetiapine was commenced. Signs of NMS resolved after discontinuation of quetiapine and administration of dantrolene. Quetiapine-induced NMS has occurred with long-term use in the elderly in the outpatient setting. However, NMS has not previously been reported after treatment of ICU delirium. NMS is an important complication to consider before prescribing quetiapine in the ICU.
Texto completo:
1
Coleções:
01-internacional
Base de dados:
MEDLINE
Assunto principal:
Antipsicóticos
/
Síndrome Maligna Neuroléptica
Tipo de estudo:
Etiology_studies
Limite:
Aged
/
Humans
Idioma:
En
Revista:
A A Pract
Ano de publicação:
2020
Tipo de documento:
Article
País de afiliação:
Irlanda